Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction - Wikidata - wikimedia - TriplyDB

Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction

Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction

http://www.wikidata.org/entity/Q37220758

about

Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.Animal models of cardiac disease and stem cell therapy.Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells.Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis.Immuno-modification of enhancing stem cells targeting for myocardial repair.Bispecific antibodies, nanoparticles and cells: bringing the right cells to get the job done.The hematopoietic system in the context of regenerative medicine.Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies.Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease.Suicide Gene Therapy for Cancer - Current Strategies.Death and inflammation following somatic cell transplantation.Development and prospects for bispecific antibody-based therapeutics in cancer and other applications.Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell.MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation.Synthesis and evaluation of an anti-MLC1 × anti-CD90 bispecific antibody for targeting and retaining bone-marrow-derived multipotent stromal cells in infarcted myocardium.Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types.

P2860

Q27677183-E5E483E9-E8B0-42CB-B733-E262BFA7734F Q34062678-4AABA79D-B534-41F1-8B0B-D80015F627D4 Q34246195-D9626D3B-C2E0-4384-B079-E4442B759541 Q34508351-2EEAC585-6D01-4196-8611-45575A8D0056 Q35083333-B9C8932A-D6D4-4554-B8B1-E44BC116E8BE Q35847709-4F9BFD89-EC2C-4FDE-9DDE-3F3F852592F0 Q35879474-47667EF9-A068-42F0-9BA4-322C378F794E Q36600044-E0CE375E-F414-43DB-8212-B6A473858BA8 Q36627127-3AE561EA-7582-44E3-A51E-081CB13A2CCA Q37016190-D4A434EB-D707-43CE-96F4-209572AAA070 Q37094511-84E7A20C-F9F7-4402-9CA5-141614C01C66 Q37253735-E375F7D9-7B59-42C8-BCA2-69FDD2CB693B Q37347017-35DACA9F-457E-41C6-B637-22C47A3BEA10 Q37870827-24E05559-156D-46D2-A034-04E508874522 Q38090680-BFCE7F34-1354-42BF-8BC0-6FB9B4B8F7ED Q38436187-A74534A9-745A-4A2F-A332-532BC9FE144D Q39356606-478CE1B0-ED07-4F3D-8F3D-21774819AB9A Q40117134-6460A69E-D12C-4799-BC8F-7AE58C870931 Q52729630-767B5CDF-6546-4B8D-A96A-E8EE63A28EEF

P2860

Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction

http://www.wikidata.org/entity/Q37220758

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting human CD34+ hematopo ...... ction in myocardial infarction

@en

Targeting human CD34+ hematopo ...... tion in myocardial infarction.

@nl

type

label

Targeting human CD34+ hematopo ...... ction in myocardial infarction

@en

Targeting human CD34+ hematopo ...... tion in myocardial infarction.

@nl

prefLabel

Targeting human CD34+ hematopo ...... ction in myocardial infarction

@en

Targeting human CD34+ hematopo ...... tion in myocardial infarction.

@nl

P1433

Q37220758-FA1B735E-77B7-4DF8-B9DD-A5B9996B6578

P1476

Q37220758-E1AFE7F3-B73A-4034-86E1-5E9B5B041FAA

P2093

Q37220758-374D2EC0-5A54-4BE6-9D72-1CDA59D48F75

Q37220758-42CB9D82-F0BF-4830-9E8C-9BE11B7F584D

Q37220758-6B56B753-AE3C-451A-B65A-8B785D770D1D

Q37220758-6D94F9DC-CCDA-4521-8AFA-499D38E186AB

Q37220758-76C28399-A265-4128-BB0D-849870F0BBC8

Q37220758-B4CEE93B-7A87-48EB-9C6C-FF0E705F5BD8

Q37220758-DC4D2026-D203-4EC6-BA59-0D15D60DA844

Q37220758-F2059C3F-8BFA-4E1D-A5CD-1F67E44E0473

P2860

Q37220758-1BB75793-66D2-4FD4-838B-97B16B7DFF9B

Q37220758-3F75F272-2804-4CAC-A1C0-DAAA7C5F9609

Q37220758-48D9FA84-7D4F-4324-AAF2-3FA15E7E15A0

Q37220758-5A4AD945-BC16-4B92-853D-89D886BD4473

Q37220758-60E2C3EA-19B9-4CE9-BD45-8F8372F211DB

Q37220758-6C405C4D-7F80-4C8E-BCDC-160B69469752

Q37220758-6F5017CA-E22E-4BB2-9F6C-5D2C871E379B

Q37220758-7D08FB47-D640-4724-A110-91E4E9864BBB

Q37220758-7E70C47D-E71C-43C2-8E86-A21A3ED59EF6

Q37220758-8D9056B4-EE88-411D-922E-E7B961AD49B0

P304

Q37220758-0242DDFC-B580-4F75-BDEB-915B7AC41791

P31

Q37220758-481EDDC3-78AB-4C5B-91F2-C0FCD432FBF2

P356

Q37220758-92EE7283-3A34-42C8-9ED8-3DD9A8B4A535

P407

Q37220758-CC65676E-E0D3-4362-8CF7-1646726D673E

P433

Q37220758-CE9A52C5-98DA-44A1-BEFF-E413353025B0

P478

Q37220758-35369DB6-8ADA-424B-85E5-E067E316C3D8

P577

Q37220758-7CB5A657-4214-4D3D-A345-F27452BF39E1

P698

Q37220758-5B8ABEB1-ED67-4823-8DEC-F049D0F2A34F

P921

Q37220758-11EA7918-C7E6-4B66-B292-E0746B057010

Q37220758-C1FF0A53-FBE0-4F0A-9538-ED5AB86DDFE2

P932

Q37220758-141CB125-78AD-48EB-AF74-8D89EFE03107

P356

JAPPLPHYSIOL.01109.2007

P1433

Journal of Applied Physiology

P1476

Targeting human CD34+ hematopo ...... ction in myocardial infarction

@en

P2093

Andy Tseng

http://www.w3.org/2001/XMLSchema#string

James F Padbury

http://www.w3.org/2001/XMLSchema#string

Lawrence G Lum

http://www.w3.org/2001/XMLSchema#string

Naohiro Yano

http://www.w3.org/2001/XMLSchema#string

Pamela A Davol

http://www.w3.org/2001/XMLSchema#string

Randall J Lee

http://www.w3.org/2001/XMLSchema#string

Ting C Zhao

http://www.w3.org/2001/XMLSchema#string

Yitang Tseng

http://www.w3.org/2001/XMLSchema#string

P2860

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

Bone marrow cells regenerate infarcted myocardium

Isolation of putative progenitor endothelial cells for angiogenesis

Marrow stromal cells as stem cells for nonhematopoietic tissues

The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Transcoronary transplantation of progenitor cells after myocardial infarction.

Cardiomyocytes can be generated from marrow stromal cells in vitro.

In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function.

Virtual reality of stem cell transplantation to repair injured myocardium.

P304

1793-1800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/JAPPLPHYSIOL.01109.2007

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18292296

http://www.w3.org/2001/XMLSchema#string

P921

P932

3792713

http://www.w3.org/2001/XMLSchema#string